Beck Bode LLC’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,671
Closed -$204K 145
2022
Q4
$204K Buy
+4,671
New +$198K 0.05% 146
2022
Q3
Sell
-5,054
Closed -$214K 227
2022
Q2
$214K Buy
+5,054
New +$220K 0.05% 173

Other funds holding BME

Beck Bode LLC's BME Position: Q1 2023 in Review

Beck Bode LLC sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 4,671 shares — an estimated $204K sold.

Beck Bode LLC first reported a position in BME in Q2 2022 and held it in 2 quarters. The position peaked at $214K in Q2 2022. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

  • Beck Bode LLC reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
  • Beck Bode LLC sold 4,671 BlackRock Health Sciences Trust shares in Q1 2023, an estimated $204K.
  • Beck Bode LLC first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 2 quarters.
  • Beck Bode LLC's BlackRock Health Sciences Trust position peaked at $214K in Q2 2022.
  • 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.